Prevalence and predictive factors of post-traumatic hypopituitarism

Area of Science:

• Neuroendocrinology
• Neurology
• Trauma Surgery

Background:

• Traumatic brain injury (TBI) can lead to significant long-term health consequences.
• Hypopituitarism, a deficiency in pituitary hormone production, is a potential complication following TBI.
• Understanding the prevalence and predictors of hypopituitarism is crucial for patient management.

Purpose of the Study:

• To determine the prevalence of hypopituitarism in patients who have sustained a TBI.
• To identify factors that predict the development of hypopituitarism after TBI.
• To compare the findings with previously reported prevalence rates.

Main Methods:

• A cross-sectional cohort study was conducted with 104 hospitalized TBI patients.
• Hormonal levels were assessed 13-27 months post-injury using an insulin tolerance test or alternative stimulation tests.
• Patients were categorized by TBI severity (mild, moderate, severe) based on Glasgow Coma Scale scores.

Main Results:

• Hypopituitarism was diagnosed in 16% of TBI patients, most commonly affecting the growth hormone (GH) axis.
• Severe TBI significantly increased the risk of pituitary insufficiency (OR 10.1, P=0.004).
• Increased intracranial pressure was also a predictor of hypopituitarism (OR 6.5, P=0.03).

Conclusions:

• The estimated prevalence of hypopituitarism post-TBI is 16%, potentially lower than previously reported.
• Severe TBI and elevated intracranial pressure are key indicators for hypopituitarism.
• Neuroendocrine assessment is recommended for patients with severe TBI, especially those with increased intracranial pressure.